Requirement of c-Jun NH2-terminal kinase for Ras-initiated tumor formation

Molecular and Cellular Biology

Volumn 31, Issue 7, 2011, Pages 1565-1576

  Cellurale, Cristina ^a   Sabio, Guadalupe ^a   Kennedy, Norman J ^a   Das, Madhumita ^a   Barlow, Marissa ^a   Sandy, Peter ^b   Jacks, Tyler ^b   Davis, Roger J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; K RAS PROTEIN; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; FIBROBLAST; GENE EXPRESSION; GENOTYPE; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CADHERINS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CONTACT INHIBITION; FIBROBLASTS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; MICE; PRECANCEROUS CONDITIONS; PROTO-ONCOGENE PROTEINS P21(RAS); SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; TUMOR STEM CELL ASSAY; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79953778211     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01122-10     Document Type: Article

References (53)

1. Alcorn, J. F., et al. 2008. Jun N-terminal kinase 1 regulates epithelial-tomesenchymal transition induced by TGF-beta1. J. Cell Sci. 121:1036- 1045.
2. Badea, T. C., Y. Wang, and J. Nathans. 2003. A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse. J. Neurosci. 23:2314-2322.
3. Bagrodia, S., B. Derijard, R. J. Davis, and R. A. Cerione. 1995. Cdc42 and PAK-mediated signaling leads to Jun kinase and p38 mitogen-activated protein kinase activation. J. Biol. Chem. 270:27995-27998.
4. Batlle, E., et al. 2000. The transcription factor snail is a repressor of Ecadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2:84-89.
5. Berx, G., and F. van Roy. 2009. Involvement of members of the cadherin superfamily in cancer. Cold Spring Harb. Perspect. Biol. 1:a003129.
6. Bost, F., et al. 1999. The Jun kinase 2 isoform is preferentially required for epidermal growth factor-induced transformation of human A549 lung carcinoma cells. Mol. Cell. Biol. 19:1938-1949.
7. Buschmann, T., et al. 2001. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21:2743-2754.
8. Cano, A., et al. 2000. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2:76-83.
9. Cavey, M., and T. Lecuit. 2009. Molecular bases of cell-cell junctions stability and dynamics. Cold Spring Harb. Perspect. Biol. 1:a002998.
10. Chen, K., M. T. Kirber, H. Xiao, Y. Yang, and J. F. Keaney, Jr. 2008. Regulation of ROS signal transduction by NADPH oxidase 4 localization. J. Cell Biol. 181:1129-1139.
11. Chen, N., et al. 2001. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res. 61:3908-3912.
12. Coso, O. A., et al. 1995. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137- 1146.
13. Cui, J., et al. 2006. c-Jun NH(2)-terminal kinase 2alpha2 promotes the tumorigenicity of human glioblastoma cells. Cancer Res. 66:10024-10031.
14. Das, M., et al. 2007. Suppression of p53-dependent senescence by the JNK signal transduction pathway. Proc. Natl. Acad. Sci. U. S. A. 104: 15759-15764.
15. Das, M., et al. 2009. Induction of hepatitis by JNK-mediated expression of TNF-alpha. Cell 136:249-260.
16. Davis, R. J. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103:239-252.
17. Dolado, I., et al. 2007. p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis. Cancer Cell 11:191-205.
18. Donehower, L. A., et al. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221.
19. Dong, C., et al. 1998. Defective T cell differentiation in the absence of Jnk1. Science 282:2092-2095.
20. Fuchs, S. Y., et al. 1998. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev. 12:2658-2663.
21. Fuchs, S. Y., V. Adler, M. R. Pincus, and Z. Ronai. 1998. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. U. S. A. 95: 10541-10546.
22. Gallo, K. A., and G. L. Johnson. 2002. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell Biol. 3:663-672.
23. Gao, Y., et al. 2005. JNK1 is essential for CD8+ T cell-mediated tumor immune surveillance. J. Immunol. 175:5783-5789.
24. Hajra, K. M., D. Y. Chen, and E. R. Fearon. 2002. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 62:1613-1618.
25. Hess, P., G. Pihan, C. L. Sawyers, R. A. Flavell, and R. J. Davis. 2002. Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. Nat. Genet. 32:201-205.
26. Hubner, A., T. Barrett, R. A. Flavell, and R. J. Davis. 2008. Multisite phosphorylation regulates Bim stability and apoptotic activity. Mol. Cell 30:415- 425.
27. Hubner, A., J. Cavanagh-Kyros, M. Rincon, R. A. Flavell, and R. J. Davis. 2010. Functional cooperation of the proapoptotic Bcl2 family proteins Bmf and Bim in vivo. Mol. Cell. Biol. 30:98-105.
28. Hui, L., K. Zatloukal, H. Scheuch, E. Stepniak, and E. F. Wagner. 2008. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J. Clin. Invest. 118: 3943-3953.
29. Jackson, E. L., et al. 2001. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-Ras. Genes Dev. 15: 3243-3248.
30. Jaeschke, A., et al. 2006. JNK2 is a positive regulator of the cJun transcription factor. Mol. Cell 23:899-911.
31. Kamata, H., and H. Hirata. 1999. Redox regulation of cellular signalling. Cell. Signal. 11:1-14.
32. Kennedy, N. J., et al. 2003. Suppression of Ras-stimulated transformation by the JNK signal transduction pathway. Genes Dev. 17:629-637.
33. Kissil, J. L., et al. 2007. Requirement for Rac1 in a K-Ras induced lung cancer in the mouse. Cancer Res. 67:8089-8094.
34. Kuan, C. Y., et al. 1999. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22:667-676.
35. Lamb, J. A., J. J. Ventura, P. Hess, R. A. Flavell, and R. J. Davis. 2003. JunD mediates survival signaling by the JNK signal transduction pathway. Mol. Cell 11:1479-1489.
36. Marino, S., M. Vooijs, H. van Der Gulden, J. Jonkers, and A. Berns. 2000. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Genes Dev. 14:994-1004.
37. Minden, A., A. Lin, F. X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157.
38. Morel, C., S. M. Carlson, F. M. White, and R. J. Davis. 2009. Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis. Mol. Cell. Biol. 29:3845-3852.
39. Onder, T. T., et al. 2008. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 68:3645-3654.
40. Perl, A. K., P. Wilgenbus, U. Dahl, H. Semb, and G. Christofori. 1998. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 392:190-193.
41. Potapova, O., et al. 2000. c-Jun N-terminal kinase is essential for growth of human T98G glioblastoma cells. J. Biol. Chem. 275:24767-24775.
42. She, Q. B., N. Chen, A. M. Bode, R. A. Flavell, and Z. Dong. 2002. Deficiency of c-Jun-NH(2)-terminal kinase-1 in mice enhances skin tumor development by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res. 62:1343-1348.
43. Siegel, P. M., and J. Massague. 2003. Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3:807-821.
44. Suh, Y. A., et al. 1999. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401:79-82.
45. Tao, J., et al. 2007. JNK2 negatively regulates CD8+ T cell effector function and anti-tumor immune response. Eur. J. Immunol. 37:818-829.
46. Tournier, C., et al. 2000. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870-874.
47. Ventura, J. J., N. J. Kennedy, J. A. Lamb, R. A. Flavell, and R. J. Davis. 2003. c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol. Cell. Biol. 23:2871-2882.
48. Weston, C. R., and R. J. Davis. 2007. The JNK signal transduction pathway. Curr. Opin. Cell Biol. 19:142-149.
49. Whitmarsh, A. J., and R. J. Davis. 2007. Role of mitogen-activated protein kinase kinase 4 in cancer. Oncogene 26:3172-3184.
50. Whitmarsh, A. J., and R. J. Davis. 1996. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:589-607.
51. Wu, R. F., and L. S. Terada. 2009. Ras and Nox: linked signaling networks? Free Radic. Biol. Med. 47:1276-1281.
52. Yang, D. D., et al. 1998. Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2. Immunity 9:575-585.
53. Yang, Y. M., et al. 2003. c-Jun NH(2)-terminal kinase mediates proliferation and tumor growth of human prostate carcinoma. Clin. Cancer Res. 9:391-401.